Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 9 | 2022 | 134 | 1.810 |
Why?
|
| Nicotine | 6 | 2022 | 210 | 0.890 |
Why?
|
| Dendrites | 1 | 2021 | 104 | 0.680 |
Why?
|
| Golgi Apparatus | 1 | 2021 | 117 | 0.670 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 453 | 0.600 |
Why?
|
| Nicotinic Agonists | 2 | 2017 | 74 | 0.600 |
Why?
|
| Up-Regulation | 6 | 2023 | 741 | 0.590 |
Why?
|
| Varenicline | 2 | 2022 | 16 | 0.580 |
Why?
|
| Endoplasmic Reticulum | 3 | 2021 | 264 | 0.510 |
Why?
|
| Receptors, Estrogen | 3 | 2003 | 417 | 0.500 |
Why?
|
| Tobacco Use Disorder | 2 | 2022 | 122 | 0.450 |
Why?
|
| Estradiol | 3 | 2003 | 256 | 0.420 |
Why?
|
| Smoking Cessation | 1 | 2017 | 272 | 0.420 |
Why?
|
| HEK293 Cells | 4 | 2021 | 706 | 0.370 |
Why?
|
| Uterus | 2 | 2003 | 228 | 0.350 |
Why?
|
| Proteins | 2 | 2003 | 816 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2021 | 1276 | 0.230 |
Why?
|
| Glycosylation | 2 | 2021 | 137 | 0.210 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 2059 | 0.210 |
Why?
|
| Cell Membrane | 2 | 2003 | 696 | 0.200 |
Why?
|
| Rats | 4 | 2021 | 4154 | 0.200 |
Why?
|
| Carrier Proteins | 2 | 2003 | 684 | 0.190 |
Why?
|
| Progesterone | 1 | 2003 | 112 | 0.190 |
Why?
|
| Estrogens | 1 | 2003 | 203 | 0.190 |
Why?
|
| Animals | 13 | 2023 | 28945 | 0.180 |
Why?
|
| Ligands | 3 | 2022 | 478 | 0.180 |
Why?
|
| Protein Biosynthesis | 1 | 2023 | 399 | 0.170 |
Why?
|
| Ventral Tegmental Area | 2 | 2013 | 46 | 0.170 |
Why?
|
| Polysaccharides | 1 | 2021 | 96 | 0.170 |
Why?
|
| Autoantigens | 1 | 2021 | 139 | 0.170 |
Why?
|
| Proteome | 1 | 2021 | 156 | 0.160 |
Why?
|
| Transcription, Genetic | 2 | 2003 | 1192 | 0.160 |
Why?
|
| Protein Subunits | 2 | 2009 | 126 | 0.150 |
Why?
|
| Neurons | 3 | 2021 | 1653 | 0.150 |
Why?
|
| Protein Transport | 4 | 2009 | 439 | 0.140 |
Why?
|
| Optical Imaging | 1 | 2017 | 51 | 0.130 |
Why?
|
| Binding Sites | 4 | 2017 | 1167 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 509 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 262 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2021 | 1761 | 0.110 |
Why?
|
| Goats | 2 | 2003 | 18 | 0.100 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2003 | 80 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2003 | 333 | 0.100 |
Why?
|
| Dopaminergic Neurons | 1 | 2013 | 30 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 1267 | 0.090 |
Why?
|
| Nucleus Accumbens | 2 | 2013 | 113 | 0.090 |
Why?
|
| Dopamine | 2 | 2013 | 282 | 0.090 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 1010 | 0.090 |
Why?
|
| Locomotion | 1 | 2013 | 146 | 0.090 |
Why?
|
| Humans | 9 | 2023 | 96127 | 0.090 |
Why?
|
| Reaction Time | 1 | 2012 | 323 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2009 | 416 | 0.080 |
Why?
|
| Lipoylation | 1 | 2009 | 37 | 0.080 |
Why?
|
| Positron-Emission Tomography | 2 | 2022 | 354 | 0.070 |
Why?
|
| Ganglionic Stimulants | 1 | 2008 | 7 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2009 | 233 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2012 | 615 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2008 | 68 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2023 | 2092 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2943 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2009 | 935 | 0.060 |
Why?
|
| Action Potentials | 1 | 2009 | 618 | 0.060 |
Why?
|
| Models, Biological | 2 | 2003 | 1815 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 515 | 0.060 |
Why?
|
| Female | 5 | 2022 | 50063 | 0.050 |
Why?
|
| Internal Ribosome Entry Sites | 1 | 2023 | 16 | 0.050 |
Why?
|
| Nuclear Localization Signals | 1 | 2003 | 10 | 0.050 |
Why?
|
| Nuclear Pore | 1 | 2003 | 12 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 12562 | 0.050 |
Why?
|
| Brain | 3 | 2022 | 2482 | 0.050 |
Why?
|
| Osteoporosis | 1 | 2003 | 131 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2003 | 233 | 0.050 |
Why?
|
| Mammals | 1 | 2023 | 261 | 0.040 |
Why?
|
| Male | 4 | 2022 | 45870 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 150 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 288 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 750 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2001 | 623 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2001 | 1157 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2017 | 297 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 310 | 0.030 |
Why?
|
| Protein Binding | 1 | 2001 | 1561 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2017 | 436 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2003 | 777 | 0.030 |
Why?
|
| Cell Line | 2 | 2009 | 2533 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1973 | 0.030 |
Why?
|
| Central Nervous System Sensitization | 1 | 2013 | 10 | 0.020 |
Why?
|
| GABAergic Neurons | 1 | 2013 | 19 | 0.020 |
Why?
|
| Long-Term Potentiation | 1 | 2013 | 51 | 0.020 |
Why?
|
| Torpedo | 1 | 2009 | 15 | 0.020 |
Why?
|
| Electric Organ | 1 | 2009 | 5 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 3147 | 0.020 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2009 | 22 | 0.020 |
Why?
|
| Acylation | 1 | 2009 | 68 | 0.020 |
Why?
|
| Biological Assay | 1 | 2009 | 84 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 181 | 0.020 |
Why?
|
| Neuromuscular Junction | 1 | 2009 | 82 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 206 | 0.020 |
Why?
|
| Time Factors | 1 | 2008 | 5585 | 0.010 |
Why?
|